Abstract. Using primary culture methods, we show that purified astrocytes from embryonic mouse or rat central nervous system (CNS) can be induced to produce interferon (IFN) activity when pretreated with a standard IFN-superinducing regimen of polyribonucleotide, cycloheximide, and actinomycin D, whereas IFN activity was not inducible in neuronal cultures derived from mouse CNS. Astrocyte IFN displays inductive, kinetic, physicochemical, and antigenic prop- 
T HE central nervous system (CNS) 1 has classically been thought to be an immunologically privileged site in that: (a) it lacks lymphatic drainage (32); (b) the CNS cells express low levels of antigens encoded by the major histocompatibility complex (MHC) which function to both initiate and effect immune responses (8, 20) ; and (c) it is protected by the blood-brain barrier which is impermeable to many substances, including the known classes of interferons (IFN a, ~, and 3') (5, 22, 30, 35) . The brain has been shown to produce high levels of IFN when injected with viruses (1, 35) or polyribonucleotides (6) , but neither the CNS cell types that produce high levels of IFN nor the function of brain IFN has been determined. IFNs are a heterogenous group of proteins that are largely defined by their ability to protect cells against viral infection (17, 28) . Three classes of IFN have been discovered which are the primary IFN products of three cell types: leucocytes, IFN-a, fibroblasts, IFN-B, and lymphocytes, IFN-3" (2). Recent work has shown that IFN-3", a T cell lymphokine, induces a dramatic increase in the expression of MHC antigens on normal and leukemic human myeloid cells (2 l), on neural cell lines (23) , and on brain cells in vitro and in vivo (41, 42) . All major 1 . Abbreviations used in this paper." CPE, cytopathic effect; CNS, central nervous system; GC, galactocerebroside; GFAP, glial fibrillary acidic protein; la, immune response associated; IFN, interferon; MHC, major histocompatibility complex; poly rl-rC, polyriboinosinic-polyribocytidylic acid; TT, tetanus toxin; VSV, vesicular stomatitis virus.
types of brain cells, including neurons, astrocytes, oligodendrocytes, and microgiia, showed enhanced MHC expression in response to IFN-3, (41, 42) .
The MHC in the mouse, termed H-2, codes for a variety of cell surface glycoproteins involved in the immune response. Two classes of molecules can be distinguished: class I transplantation antigens (H-2 K, D, and L) are present on most cells of the body, but these antigens are undetectable on normal brain cells (8) . H-2 antigens mediate immune reactions of cytotoxic T cells (44) . Class II, the immune response associated (Ia) antigens, are found predominantly on B cells, macrophages, and dendritic cells, and function to present foreign antigens to regulatory T lymphocytes. Approximately 1-2% of CNS cells have been reported to be Ia +, but the nature and origin of these cells has not been established (14, 36) . IFN-3, modulation of MHC antigens on neurons and/or glia might enable normally sequestered immunoincompetent cells of the brain to participate in T cell-mediated responses, and may play an important role for brain diseases that have an immunological component. However, this cooperation of brain and immune cells appears to involve passage of T cells across the blood-brain barrier, so that they enter the brain and release lymphokines as IFN-3", which normally cannot pass the blood-brain barrier (5, 22, 30, 35) .
In this paper, we show that cells (astrocytes) within the CNS produce IFN that is biologically and antigenically similar to expression on a subpopulation of astrocytes. These results suggest that astrocyte IFN has an important role in defending the brain against viruses and in the generation of immune responses in the CNS.
Materials and Methods

Cell Cultures
,4strocytic Cultures. Cerebral cortices were dissected from embryonic CBA/J mice (E-19), freed of meninges, and dissociated by gentle repetitive pipetting. The cell suspensions were plated on collagen-polylysine coated tissue culture dishes. Loosely adherent oligodendrocytes were preferentially removed by gently pipelting a stream of medium across the surface of the cells. Cultures were grown to confluence in N5 medium (18) that contained 5% horse serum, then treated with l0 -~ M cytosine arabinoside for 48 h to kill rapidly dividing cells.
Neuronal Cultures. Neuronal cultures were obtained by dissociation of 15-d CBA/J mouse embryo brains. The tissue was disrupted into a cell suspension by gentle trituration and the cells were grown on collagenopolylysine coated tissue culture dishes in N5 medium that contained 5% neurutrophic factor from horse serum as described (18) .
Immunohistochemical Procedures
Cell cultures were immunohistochemically labeled as described by Keane et al. (19) . For immunolabeling of the cell surface (tetanus toxin [TT] , A2B5, galactocerebroside [GC], H-2, and la), cultures were treated with antibody to cell surface antigens, washed in N5 medium, and exposed to fluorochromecoupled second antibody. Cells were fixed in 10% buffered formalin. For labeling of intracellular antigens (neurofilaments, glial fibrillary acidic protein [GFAP]), cells were fixed in 10% buffered formalin, permeabilized with 95% ethanol at -20"C, and exposed to antibodies to intracellular antigens. The cultures were washed in N5 medium and treated with fluorochrome-coupled second antibodies. Cells were then mounted in 50% glycerol/phosphate-buffered saline (PBS) and visualized in a Nikon diaphot epifluorescence microscope equipped with the appropriate filters.
Antibodies and Toxins
Expression of H-2K k and Ia antigens on CBA/J (H-2K k, D k) mouse neurons, astrocytes, and oligodendrocytes was detected by double immunobistochemical labeling of cells using anti-H-2K k monoclonal antibodies from cell line l 1-4-1 (American Type Culture Collection, Rockville, MD) and anti-la monoclonal antibodies from cell line 14-4-4S (American Type Culture Collection). Specificity of binding was evaluated in control labelings using monoclonal antibodies (34-1-2S) of the same class (IgG 2a), but specific for a different haplotype (H-2K d, I~). Rabbit anti-neurofilament (43) was a gift of Dr. S.-H. Yen (Albert Einstein University), rabbit anti-GFAP (10) was a gift of Dr. L. Eng (California Institute of Technology), and rabbit-anti-GC (31) was a gift of Dr. K. Fields (Albert Einstein University). All rabbit antisera were used at a 1:150 dilution. Mouse monoclonal antibodies to the neuronal marker, A2B5 (9) (a gift of Dr. M. Nirenberg, NIH), and mouse monoclonal antibodies of H-2 and Ia antigens were used at a 1:200 dilution. Rabbit antibodies were visualized with either tetramethylrhodamine-or fluoresceinisothiocyanate-conjugated goat antibodies to rabbit immunoglobulins (IgA, IgG, IgM, heavy and light chains, Cappel Laboratories, Cochranville, PA). Mouse antibodies were visualized with tetramethylrhodamine-or fluorescein isothiocyanate-conjugated goat immunoglobulins to mouse immunoglobulins (Cappel Laboratories). Antibodies and staining procedures for GC, GFAP, and TT receptors were according to previously described procedures (19) .
Superinduction of lFN
Superinduction was done by preincubating astrocytes or neurons with polyriboinosinic-polyribocytidylic acid (poly rl-rC) (50 ~g/ml) and cycloheximide ( 10 ~g/ml) for 6 h and with acfinomycin D (1 ug/ml) for the final 2 h of the induction period (15, 29, 34) . Astrocytic cultures were washed thoroughly with N5 medium that contained 5% horse serum, and then incubated with N5 medium for 24 h. Neuronal cultures were washed thoroughly with N5 medium that contained 5% neurotrophic fraction from horse serum (18) , and then incubated in N5 medium for 24 h. Neuronal cultures were also treated with other lFN-inducing regimens using either phytohemagglutinin (5-500 ug/ml) (40) or B-lipopolysaccharide (5-500 ~g/ml) (26) for 6 h. No measurable IFN activity was obtained from neurons, even after the superinducing regimen.
Cytopathic Effect (CPE) Assay
IFN activity was m~asured by the CPE assay that is based on dye (crystal violet) incorporation into fixed cells (3, 11) . Mouse L929 cells were plated in 96-well Costar microtiter dishes (Costar, Cambridge, MA) at a density of I x 104 cells/ ml and grown to confluence for 24 h. L929 cells were then incubated with medium from superinduced astrocytes or neurons for 24 h, and then infected with vesicular stomatitis virus (VSV, Indiana strain) that normally lyses these cells. After 24 h of infection, L929 cells were washed with N5 medium, fixed, and stained with 0.5% crystal violet, washed with distilled water, and air-dried. Crystal violet stain was eluted by addition of ethylene glycol monoethyl ether to each well and absorbance (OD59o) determined in a Titertek Multiscan Photometer. IFN activity was determined by cell survival, calculated as percent dye uplake (3, 11) . For each experiment, log dilutions of standard mouse IFNa//3 (Lee BioMolecular, Inc.) were co-assayed with superinduced astrocyte or neuronal conditioned medium samples to determine the titer of IFN.
Neutralization Assays
Mouse astrocyte IFN (500 U/ml) was incubated with rabbit antiserum against mouse IFN-a//3 (Lee BioMolecular, Inc.) or IFN-3, (a gift from Dr. S. Baron, University of Texas, Galveston) with neutralizing specific activity varying from 200 to 5,000 neutralizing U/ml for 3 h at 37"C and the antibody-IFN mixture tested for antiviral activity in the CPE assay (3, 11). 
Induction of H-2 Antigens in the Brain
Results
Purified astrocytic and neuronal cultures used in these studies are shown in Figs. 1 and 2, respectively. The cell types present were assessed immunohistochemically with cell-type specific antibody markers. The majority of cells (>99%) in cortical astrocytic cultures displayed a flattened, sheet-like morphology ( Fig. 1 a) , and stained with antibodies to GFAP (Fig. I b) , a specific marker for astrocytes (4) . The remaining cells (<1 %) were either fibrous astrocytes, identified by binding of antibodies to GFAP, TT (27) and monoclonal antibodies to AM (9), or oligodendrocytes as evidenced by binding of anti-GC, a marker for oligodendroglia (31) .
Neuronal cultures were obtained by dissociation of 15-d CBA/J mouse embryo brains (Fig. 2) . The neuronal nature of the majority of cells (95%) was confirmed by their ability to fire action potentials (18) and to bind antibodies to NF (Fig. 2, a and b) , TT (Fig. 2, c and d) , and AM (Fig. 2, e and f) . The remaining cells (5%) in the neuronal cultures were astrocytes as evidenced by staining with anti-GFAP antibodies (Fig. 2, g ence of neurons assume a process-bearing morphology, much like that of neurons (Fig. 2, g and h) , whereas astrocytes cultured alone have a flattened, sheet-like appearance (Fig. 1,  a and b) (13) .
Astrocytic and neuronal cultures were superinduced by a 6-h exposure to poly rl-rC (50 kg/ml) and cycloheximide (10 jig/ml) (Fig. 3a) . For the final 2 h of the induction period, actinomycin D (1 jAg/ml) was added. Cultures were extensively washed and then incubated from 1 to 24 h in a N5 medium that contained 5% horse serum . IFN antiviral activity in the collected medium was assayed by its ability to protect cells against VSV infection in the CPE assay . Superinduction of astrocyte IFN yielded from 500 to > 10,000 U/ IFN produced by astrocytes was collected at 3-h intervals after the superinduction followed by extensive washing of cells with N5 medium between collection periods . Astrocyte IFN activity in each sample was measured by the CPE assay as described in Materials and Methods.
ml IFN activity (Fig. 3a) . No measurable IFN activity was detected in either uninduced astrocyte cultures or purified neuronal cultures treated with the same superinduction regimen or with other IFN-inducing protocols using phytohemagglutinin (a T cell mitogen) or B-iipopolysaccharide (a B cell mitogen) (Fig. 3a) . Thus, it appears that IFN activity is produced by astrocytes, but not by neurons . Fig. 3 b shows the kinetics of astrocyte IFN induction . After the termination of the 6-h induction period, IFN produced by astrocytes was collected at 3-h intervals (up to 24 h) followed by extensive washing with fresh media between collection points. The aliquots ofastrocyte-conditioned media collected at each 3-h interval were then assayed for antiviral activity by the CPE assay. Induction of astrocyte IFN activity was rapid with the highest levels produced during the first 3 h after the 6-h induction period . IFN activity gradually declined so that no measurable astrocyte IFN activity remained 15 h after the induction period . The kinetics ofastrocyte IFN induction are similar to those reported for IFN-a and IFN-(3, Table I shows physical and biological properties displayed by astrocyte IFN . Astrocyte IFN is sensitive to trypsin digestion, which suggests that it is a protein . Astrocyte IFN activity is stable at both pH 2.0 for at least 24 h and at 56°C for 3 h, characteristic properties of IFN-a and IFN-a, but not IFN--y. Since the antiviral protection conferred by IFN-a, 0, and y is species-and cell-specific, we tested host cell specificity of mouse astrocyte IFN on several different fibroblast cell lines often used in the CPE assay (Table I) . Antiviral activity was greatest on homologous mouse cell lines (-75% of VSVinfected L929 cells were protected from viral infection), whereas little or no protection was conferred on human foreskin fibroblasts or rat kidney fibroblasts . Additionally, induced IFN from neonatal Sprague-Dawley rat cortical astrocytes protected -70% of VSV-infected rat kidney fibroblasts, but afforded little or no protection for VSV-infected human foreskin fibroblasts or mouse L929 fibroblasts (data not shown). These results show that the antiviral protection conferred by astrocyte IFN is species-specific. The response to inducers, kinetics of induction, and physical properties of astrocyte IFN are similar to those reported for IFN-a and IFN-, but not for IFN-y (29, 34) .
To test whether astrocyte IFN is antigenically similar to other IFN classes, medium conditioned by superinduced astrocytes was incubated with dilutions of rabbit antiserum against mouse IFN-a/(3 or IFN-y (Table II) . After a 3-h incubation ofantibody and astrocyte IFN mixtures, the astrocyte IFN antiviral activity was measured by the CPE assay. Antiserum against mouse IFN-a/# effectively neutralized astrocyte IFN antiviral activity, while antiserum against mouse IFN-y did not . Thus, astrocyte IFN is antigenically similar to IFN-a/,a and dissimilar to IFN-y. Table I . Physical and Biological Properties ofAstrocyte IFN Mouse astrocyte IFN was superinduced and collected as described in Materials and Methods. Three (0.5 ml) aliquots were taken. One sample was treatedwith trypsin (0 .25%) for 3 h and the reaction stopped with 0.25% soybean trypsin inhibitor . The second sample was acidified (pH 2.0) with 1 .0 N HCl for 24 h and then neutralized to pH 7.0 with 1.0 NNaOH. The third sample was heated to 56°C for 3 h and then cooled to 37°C. IFN activity in all three samples was then assayed for antiviral protection on mouse L929 fibroblasts in the CPE assay. Samples containing 0.25% trypsin and 0.25% soybean trypsin inhibitor did not affect viability (crystal violet uptake) of uninfected mouse L929 fibroblasts . Cross-species activity of mouse astrocyte IFN was tested on mouse L929 cells, human foreskin fibroblasts, and rat kidney fibroblasts. L929 cells, human foreskin fibroblasts (1 x 10`cells), and rat kidney fibroblasts (2 .5 x 104 cells) were seeded in 96-well Costar microtiter dishes and grown to confluence. Antiviral activity conferred by mouse astrocyte IFN on each cell type was measured by the CPE assay. Each mean (± SD) is based on six values (n = 6). Mouse astrocyte IFN (500 U/ml) was incubated with rabbit antiserum against mouse IFN-a//3 or IFN-7 (neutralizing specific activity varying from 200 to 5,000 neutralizing U/ml) for 3 h at 37"C and tested for antiviral activity in CPE assay as described in Materials and Methods. Each mean (_+SD) was based on eight samples (n = 8). 
Table III. Induction of MHC Antigens on 48 h Cultured CBA/J Brain Cells
H-2K ~ H-2K d la
Inducible Expression of H-2 Antigens on Brain Cells In Vitro
Since brain cells and many other cell types respond to IFN-7 by enhancing levels of H-2, and in some cases Ia antigens (41, 42) , we examined brain cells to determine whether MHC antigen expression could be induced by astrocyte IFN, IFNa/B, or IFN-/~ (Table III) . Single cell suspensions were prepared from l-d-old CBA/J mice and then treated with different concentrations of IFN (1-500 U/ml). After 48 h of exposure to IFN, the expression of MHC antigens was determined by indirect immunofluorescence staining using monoclonal antibodies against H-2 and Ia antigens. Treatment with astrocyte IFN or IFN-a/~ caused expression of H-2 antigens on -25% of the brain cell population, whereas treatment of cells with IFN-~ showed H-2 levels similar to uninduced brain cell controls (Table III) . Detection of the observed fluorescence was specific for H-2 antigens in that monoclonal antibodies (13-1-2S), specific for a different H-2 haplotype (H-2K d, I~), did not bind to brain cells of CBA/J ( H -2 K k, D k) mice. None of the IFN treatments stimulated the expression of Ia antigens.
Identification of Cell Types That Respond to Astrocyte IFN
To determine which CNS cell types respond to astrocyte IFN, we double-labeled cells using anti-H2 or Ia monoclonal antibodies together with cell-type-specific antibodies that identify the major CNS cells. In neuronal cultures (4 wk old), >95% of the cells are neurons and the remaining 5% of the cells are process-bearing astrocytes (Fig. 2) . When neuronal cultures were treated with 1, 10, 50, 100, 500, or 1,000 U of astrocyte IFN, IFN-a/#, or IFN-#, no detectable levels of H-2 or Ia antigens were found on neurons (Fig. 3) . However, when we double-labeled the population (5%) of process-beating astrocytes in these cultures, ~45% of the astrocytes showed enhanced expression of H-2 antigens in response to treatment with either astrocyte IFN or IFN-a/# (Table IV, Fig. 4, a-c) . This selective response of a subpopulation of astrocytes to IFN-a/~ or astrocyte IFN is in contrast to the action of IFN-~, which has been reported to enhance the expression of H-2 antigens on all CNS cell types (41, 42) .
Since the antiviral activity of astrocyte IFN and IFN-a/~ in the CPE assay was neutralized by anti-IFN-a//~, but not by anti-IFN-3, antibodies, we tested whether the MHC-inducing activity showed a similar neutralization with these antisera (Fig. 4, d-i ). H-2 inducing activity of astrocyte IFN was effectively neutralized by anti-IFN-a//3 (Fig. 4, d-f ), but not by anti-IFN-,y (Fig. 4, g-i) antibodies. Anti-IFN-a/~ also neutralized the H-2 inducing activity of IFN-a/# (not shown).
No detectable Ia staining was observed on cells treated with any of the IFN classes (Table IV) . Thus it appears that astrocyte IFN and IFN-a//3 enhance the expression of H-2 antigens on a subpopulation of astrocytes within the CNS.
Failure of H-2 process-bearing astrocytes to express MHC antigens could result from a suppressive trophic response from the neuronal population. To test this possibility, we cultured pure populations of astrocytes from cerebral cortices of embryonic mice, induced them with astrocyte IFN, IFN-a/#, and IFN-/~, and then determined the expression of H-2 and Ia antigens by immunohistochemical staining (Fig. 5 , Table  IV ). Astrocytes cultured for 1-3 wk did not respond to IFN induction with enhanced MHC antigen expression. Cells in g-i) . Bar, 20 , m. these cultures formed a confluent monolayer that consisted of two populations of astrocytes: those that stained intensely with anti--GFAP antibodies and cells that showed diffuse GFAP staining. By 3--4 wk of culture all of the cells stained intensely with anti--GFAP antibodies. Induction of older cultures (4-6 wk) with astrocyte IFN or IFN-a//3 resulted in ~40% of the astrocytes expressing detectable H-2 staining (Table IV) . While effectively enhancing the expression of H-2 antigens, IFN-a//~ and astrocyte IFN caused alterations in the cytoskeletal arrangement of G F A P filaments (Fig. 5, b and h ). The MHC inducing activity was neutralized by anti-IFN-a/~/ (Fig. 5f ), but not by IFN--r antibodies (Fig. 5 i) . None of the IFNs induced the expression of Ia antigens on astrocytes (Table IV) .
To determine whether the other major glial cell population, the oligodendroglia, showed enhancement of H-2 or la antigens in response to astrocyte IFN, we treated oligodendrocytes with 10 U of astrocyte IFN for 48 h and then double-labeled the cells with rabbit antibodies to the oligodendroeyte-specific marker, galactocerebroside and with monoclonal antibodies to H-2 or Ia antigens (Fig. 6, a-c) . None of the oligodendrocytes examined showed detectable levels of H-2 or Ia antigens after exposure to astrocyte IFN (Fig. 6 c) .
Inducible expression o f H-2 Antigens in the Brain
We attempted to test whether the H-2 induction observed in vitro had relevance to a physiological response in vivo. Astrocyte IFN, IFN-a/~, IFN-~, or supernatants from uninduced astrocyte cultures that exhibit no IFN activity were injected into cerebra of l-d-old CBA/J mice. After different periods of treatment, brains were dissected, the meninges removed, and the tissue was dispersed into single cell suspensions. The cells were then stained for H-2 and Ia expression. appear to cross the blood-brain barrier (5, 22, 30, 35) , IFN produced by astrocytes may play an important role in CNS immune responses by enhancing the expression of MHC antigens on previously immunologically incompetent brain cells, which then become competent to participate in T cellmediated responses. This mechanism may contribute to CNS degenerative diseases such as multiple sclerosis, where T cells infiltrate the CNS (7, 38) . The brain has been shown to produce high levels of IFN when injected with viruses (1, 35) or poly d-rC (6) . Within the brain there also appears to be compartmentation of IFN. Luby and co-workers (25) found that patients dying from St. Louis encephalitis had IFN in frontal lobes, cerebellum, basal ganglia, but not brain stem. Marked differences in IFN content between certain areas of the brains infected with Western equine encephalitis have also been reported (24) . It is possible that astrocytes in different locations of the brain produce IFN, thus accounting for the compartmentation of IFN observed in CNS infections and diseases. We are currently investigating whether astrocytes from different CNS locations can be induced to produce IFN activity. (12) , whereas from Southern blot analysis on chromosomal DNA the number of IFN-a genes was estimated to be at least 9-11 (33, 45) . Since there are multiple subclasses of IFN-a//3, it is possible that astrocytes exclusively produced one IFN subtype that is not expressed by other cells of the body.
Tamm and co-workers (39) have reported IFN-# disorganizes the microtubule and 10-nm filament network in a subpopulation of macrophages. Microtubules from the peripheral cytoplasm coiled around the nucleus without evidence of depolymerization after IFN-/3 treatment. We have found that IFN-a/~ and astrocyte IFN treatment of astrocytes results in the disorganization of intermediate GFAP filaments, and we have obtained data that prolonged astrocyte IFN treatment of neurons leads to disorganization of neurofilaments in neurons (data not shown). Whether these intermediate cytoskeletal alterations affect cellular functions is unclear, but these observations suggest a possible explanation for the production of neurofibrillary tangles and neuritic plaques in Alzheimer's and Parkinson's diseases (37) .
CNS cells have been categorized by morphological and antigenic criteria (27) . Two broad classes of astrocytes, protoplasmic and fibrous, differ in their antigenic phenotype, developmental history, morphology, and location in the CNS. We have demonstrated that cells within each of these broad astrocyte categories can be further subdivided based on their ability to express H-2 antigens in response to IFN treatment. Whether these H-2 ÷ astrocytes are functionally different from H-2-astrocytes remains to be determined, but clearly the CNS probably contains many more astrocyte subtypes than previously realized.
